Literature DB >> 22912361

Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification.

Jian Sun1, Qunpei Yang, Zhaohui Lu, Miaoxia He, Li Gao, Minghua Zhu, Lu Sun, Lixin Wei, Min Li, Cuiling Liu, Jie Zheng, Weiping Liu, Gandi Li, Jie Chen.   

Abstract

To estimate the distribution of lymphoid neoplasms in China, we conducted a comprehensive analysis, based on subtype, age, sex, and lesion, of primary and resected biopsy specimens of 4,638 lymphoid neoplasms diagnosed from 2004 to 2008 at 5 large hospitals. Of the 4,638 patients, mature B-cell neoplasms accounted for 64.3% of all lymphoid neoplasms, mature T/NK-cell neoplasms for 23.3%, and Hodgkin lymphoma for 8.6%. The most common subtype was diffuse large B-cell lymphoma (36.2%), followed by extranodal NK/T-cell lymphoma, nasal type (11.0%), classic Hodgkin lymphoma (8.4%), extranodal marginal zone B-cell lymphoma (7.7%), plasmacytic neoplasm (5.0%), and peripheral T-cell lymphoma, not otherwise specified (3.9%). For most lymphoid neoplasm subtypes, male subjects showed higher rates than female subjects. In summary, our study showed that the epidemiologic features of lymphoid neoplasms in China are distinct from those in Western countries and similar in many ways to those in other countries of the Far East.

Entities:  

Mesh:

Year:  2012        PMID: 22912361     DOI: 10.1309/AJCP7YLTQPUSDQ5C

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  98 in total

1.  Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.

Authors:  Anamarija M Perry; Jacques Diebold; Bharat N Nathwani; Kenneth A MacLennan; Hans K Müller-Hermelink; Martin Bast; Eugene Boilesen; James O Armitage; Dennis D Weisenburger
Journal:  Haematologica       Date:  2016-06-27       Impact factor: 9.941

2.  Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.

Authors:  Y Yang; Y-J Zhang; Y Zhu; J-Z Cao; Z-Y Yuan; L-M Xu; J-X Wu; W Wang; T Wu; B Lu; S-Y Zhu; L-T Qian; F-Q Zhang; X-R Hou; Q-F Liu; Y-X Li
Journal:  Leukemia       Date:  2015-02-20       Impact factor: 11.528

Review 3.  Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.

Authors:  Bradley M Haverkos; Zenggang Pan; Alejandro A Gru; Aharon G Freud; Rachel Rabinovitch; Meng Xu-Welliver; Brad Otto; Carlos Barrionuevo; Robert A Baiocchi; Rosemary Rochford; Pierluigi Porcu
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

4.  Hematologic malignancies in elderly patients.

Authors:  Moustapha Hassan; Manuchehr Abedi-Valugerdi
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

5.  L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphoma.

Authors:  Shanshan Bu; Fangfang Yuan; Xudong Wei; Qingsong Yin; Yufu Li; Ruihua Mi; Haiping Yang; Hongyi Li; Shoubei Ge; Yanyan Liu; Yongping Song
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

6.  Current status and progress of lymphoma research in East Asian countries: Introduction and planning.

Authors:  Junji Suzumiya
Journal:  Int J Hematol       Date:  2018-02-28       Impact factor: 2.490

Review 7.  Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia/lymphoma in Japan.

Authors:  Hiroaki Miyoshi; Koichi Ohshima
Journal:  Int J Hematol       Date:  2018-03-03       Impact factor: 2.490

8.  Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.

Authors:  Jingwen Wang; Liqiang Wei; Jin Ye; Lei Yang; Xin Li; Jia Cong; Na Yao; Xueying Cui; Yiping Wu; Jing Ding; Le Zhang
Journal:  Int J Hematol       Date:  2017-08-30       Impact factor: 2.490

9.  Pembrolizumab in newly diagnosed EBV-negative extranodal natural killer/T-cell lymphoma: A case report.

Authors:  Samia Asif; Madeline Begemann; Joseph Bennett; Rawish Fatima; Ashiq Masood; Shahzad Raza
Journal:  Mol Clin Oncol       Date:  2019-01-23

Review 10.  Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China.

Authors:  Xianping Lu; Zhiqiang Ning; Zhibin Li; Haixiang Cao; Xinhao Wang
Journal:  Intractable Rare Dis Res       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.